Skip to content
Search

Latest Stories

DHSC adds further items to October price concessions

The Pharmaceutical Services Negotiating Committee has announced that the Department of Health and Social Care (DHSC) has granted price concessions to more items for the month of October 2021.

DrugPack sizePrice Concession
Clomipramine 50mg capsules28£8.60
Glyceryl trinitrate 400micrograms/dose pump sublingual spray180£2.83
Hypromellose 0.5% eye drops10£1.17
Lercanidipine 10mg tablets28£2.99
Lercanidipine 20mg tablets28£2.96
Loratadine 5mg/5ml oral solution100£6.92
Orlistat 120mg capsules84£25.50
Perindopril erbumine 8mg tablets30£2.14
Tolbutamide 500mg tablets28£26.00

The DHSC previously announced (15.10.2021) the following list of price concessions:


DrugPack sizePrice Concession
Glyceryl trinitrate 400micrograms/dose pump sublingual spray200£2.83
Lamotrigine 5mg dispersible tablets sugar free28£8.43
Methocarbamol 750mg tablets100£12.37
Pioglitazone 45mg tablets28£2.40
Timolol 0.25% eye drops5£4.16
Timolol 0.5% eye drops5£4.10
Trimethoprim 50mg/5ml oral suspension sugar free100£10.99
Ursodeoxycholic acid 250mg capsules60£10.53

Contractors can find information on the first batch of price concessions here, and learn about the process involved on PSNC's website.

A price concession only applies for the month in which it is granted. No additional prescription endorsement are required as the new price is automatically applied by the NHS BSA to all items submitted for payment in the same month for which a price concession is granted.

PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated October 2021 Drug Tariff price.

More For You

Vaccine-preventable infections costing UK billions

Effective interventions are needed to prevent hospitalisations

Vaccine-preventable infections costing UK billions

Effective interventions are having a positive impact but more needs to be done to combat vaccine-preventable infections after data revealed today showed that it accounted for 20 per cent of hospital bed usage in the UK between 2023 to 2024 at a cost of almost £6 billion.

The return of social mixing, international travel and migration following the COVID-19 pandemic have contributed to the rise in both endemic disease and vaccine-preventable infections, according to the UK Health Security Agency's (UKHSA).

Keep ReadingShow less
Economic analysis of pharmacy finances will be published ‘imminently’ - Stephen Kinnock

Stephen Kinnock also confirms that the outcome of the negotiations with CPE will be announced "very soon."

parliamentlive.tv

NPA collective action “premature, unnecessary and detrimental to patients” - Stephen Kinnock

Health Minister Stephen Kinnock has announced that the government will be releasing the independent economic analysis of pharmacy finances “imminently.”

Responding to a question from shadow health minister Dr. Luke Evans in Parliament today (25), Kinnock criticised the National Pharmacy Association’s (NPA) collective action as “premature, unnecessary, and detrimental to community pharmacy patients.”

Keep ReadingShow less
NPA members are expected reduce opening hours and services from next week

NPA members are expected reduce opening hours and services from next week

Pic credit: iStock

NPA will become more “militant” as wait for pharmacy contract goes on

The government has been warned by the National Pharmacy Association (NPA) that community pharmacy will not back down from collective action and reducing opening hours from April 1st.

NPA board member, Ashley Cohen, told LBC today that the sector was in a "desperate situation" and that the representative body will do “whatever we can to protect our sector”.

Keep ReadingShow less
Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.

Keep ReadingShow less
Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less